Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2003
05/08/2003WO2003037347A1 Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity
05/08/2003WO2003037345A1 Pharmaceutical formulations comprising substituted xanthine compounds
05/08/2003WO2003037344A1 Pharmaceutical compositions for the treatment of leukemia comprising dioxolane nucleosides analogs
05/08/2003WO2003037343A1 Composition comprising folic acid and carnitine useful to enhance male fertility
05/08/2003WO2003037342A1 Method of treating depression with delta receptor agonist compounds
05/08/2003WO2003037341A1 Method for the treatment of overactive bladder
05/08/2003WO2003037340A1 Inhibitors of abc drug transporters in cancer cells
05/08/2003WO2003037339A1 Interferon $g(g) production promoter
05/08/2003WO2003037338A2 Modulators of the cholesterol biosynthetic pathway
05/08/2003WO2003037337A1 Depot formulations of iloperidone and a star polymer
05/08/2003WO2003037336A1 1-(5-sulfonyl-pyridin-2-yl)-5-(methylidene-cycloalkylmethoxy)-1h-pyrazole-4-carbonitrile derivatives and other compounds as cyclooxygenase inhibitors for the treatment of arthritis, neurodegeneration and colon cancer
05/08/2003WO2003037335A1 5-heteroatom-substituted pyrazoles
05/08/2003WO2003037334A1 Method for treating or preventing symptoms of hormonal variation including hot flashes
05/08/2003WO2003037333A1 Pyridine derivatives as nmda-receptor subtype blockers
05/08/2003WO2003037332A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
05/08/2003WO2003037331A1 Use of tetramisole and its derivatives against spore producing microorganisms
05/08/2003WO2003037330A1 Sulfonyl-and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors
05/08/2003WO2003037329A1 Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome
05/08/2003WO2003037328A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps)
05/08/2003WO2003037327A1 N-substituted pyrrolidin derivatives as dipeptidyl peptidase iv inhibitors
05/08/2003WO2003037326A1 Solid phase synthesis of chemical libraries
05/08/2003WO2003037325A1 Hydroxy substituted amides for the treatment of alzheimer's disease
05/08/2003WO2003037324A1 Use of an opuntia ficus-indica extract and compounds isolated therefrom for protecting nerve cells
05/08/2003WO2003037323A2 Inhibitors of the fatty acid oxidation for prophylaxis and treatment of diseases related to mitochondrial dysfunction
05/08/2003WO2003037322A1 Combination of an atp-competitive inhibitor of bcr/abl kinase activity and a tyrphostin analog
05/08/2003WO2003037321A1 Alkane diol derivatives as therapeutic agents for the treatment of bone conditions
05/08/2003WO2003037320A1 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect
05/08/2003WO2003037319A1 Method for reducing psa levels
05/08/2003WO2003037318A1 Use of n,n-diethyl-2-[-4-(phenylmethyl)-phenoxy]ethanamine monohydrochloride (dppe) in cancer therapy
05/08/2003WO2003037317A1 Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
05/08/2003WO2003037316A1 Peroxisome proliferator activated receptor ligands and process for producing the same
05/08/2003WO2003037315A1 Pharmaceutical composition containing chalcone or its derivatives for matrix metalloproteinase inhibitory activity
05/08/2003WO2003037314A2 Medical compositions for intravesical treatment of bladder cancer
05/08/2003WO2003037313A2 Methods for the treatment of addiction
05/08/2003WO2003037312A2 Ribavirin syrup formulations
05/08/2003WO2003037311A2 Method for treating retroviral infections
05/08/2003WO2003037309A2 USE OF 4α PHORBOL
05/08/2003WO2003037308A2 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion
05/08/2003WO2003037307A1 Volatilization of a drug from an inclusion complex
05/08/2003WO2003037306A2 Inhalation of vapour of therapeutical substances, like e.g. cannabis extract
05/08/2003WO2003037304A1 Controlled release compositions for macrolide antimicrobial agents
05/08/2003WO2003037303A1 Spray drying methods and compositions thereof
05/08/2003WO2003037300A1 Gastric raft composition
05/08/2003WO2003037299A1 Novel formulation
05/08/2003WO2003037298A2 Bowel cleansing agent
05/08/2003WO2003037296A2 Methods and dosage forms for improving the bioavailability of therapeutic agents
05/08/2003WO2003037295A2 Micelle compositions containing pegylated phospholipids and a photosensitizer
05/08/2003WO2003037291A1 Cream for treatment of skin injured by the sun
05/08/2003WO2003037290A1 Skin preparation comprising a tocopherol derivative for external application
05/08/2003WO2003037289A1 Skin preparation comprising a tocopherol derivative for external application
05/08/2003WO2003037286A1 Composition in the form of an emulsion that can be used to treat plantar bromhidrosis and/or hyperhidrosis
05/08/2003WO2003037284A1 Oral hygiene composition
05/08/2003WO2003037278A1 Surfactant-containing cosmetic cleaning emulsions
05/08/2003WO2003037274A2 Pyrazole-amides and-sulfonamides
05/08/2003WO2003037271A2 Compounds, pharmaceutical compositions and methods of use therefor
05/08/2003WO2003037265A2 Method of treating viral infections
05/08/2003WO2003037263A2 Sunspot skin cream
05/08/2003WO2003037261A2 Methods and compositions for the treatment and diagnosis of pain disorders using 9805
05/08/2003WO2003037259A2 Methods for the prevention or treatment of bacterial and fungal infections
05/08/2003WO2003037258A2 Methods and compositions for the treatment and diagnosis of pain disorders using 2047
05/08/2003WO2003037253A2 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616
05/08/2003WO2003037248A2 Fibrin nanoparticles and uses thereof
05/08/2003WO2003037246A2 Compositions and methods for prostate and kidney health and disorders, an herbal preparation
05/08/2003WO2003037220A1 Improved endoprosthetic device
05/08/2003WO2003037168A2 Methods and formulations for minimizing spasticity in blood vessel grafts
05/08/2003WO2003037166A2 Devices and methods for the restoration of a spinal disc
05/08/2003WO2003037165A2 System and method for the pretreatment of the endplates of an intervertebral disc
05/08/2003WO2003037164A2 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
05/08/2003WO2003037159A2 An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
05/08/2003WO2003037095A1 Non-lauric, non-trans, non-temper fat compositions
05/08/2003WO2003028001A8 Method and pharmaceutical composition for inducing cancer cell-specific apoptosis by combination with tnf family proteins and flavopiridol
05/08/2003WO2003024189A3 Method of modulating sodium ion absorption in epithelial cells
05/08/2003WO2003020254A8 Pharmaceutical composition comprising (-)-secoisolariciresinol
05/08/2003WO2003017929A3 Method for treating bronchial constriction and bronchospasm
05/08/2003WO2003014322A3 Proteins associated with cell growth, differentiation, and death
05/08/2003WO2003012105A3 Vegf isoform
05/08/2003WO2003011224A3 Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
05/08/2003WO2003009805A3 Analgesic methods using endothelin receptor ligands
05/08/2003WO2003005955A3 Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus
05/08/2003WO2003004000A3 Topical composition for treating pain
05/08/2003WO2003002595A3 Dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
05/08/2003WO2003000633A3 A process for the isolation of a major harmful oxidant from cigarette smoke
05/08/2003WO2003000182A3 Ppar-alpha ligands for the treatment or prevention of cachexia
05/08/2003WO2002102304A3 Gum resin as a carrier for topical application of pharmacologically active agents
05/08/2003WO2002098482A3 System for osmotic delivery of pharmaceutically active agents
05/08/2003WO2002096432A3 Hypotensive lipid (prostaglandin derivatives) and timolol compositions and methods of using same
05/08/2003WO2002094836A3 Methods for preparation and use of psorospermin analogs
05/08/2003WO2002090974A3 Method for detecting progredient chronic dementia, and associated peptides and detection reagents
05/08/2003WO2002088124A3 Pyrazolo'1,5-a!pyridine derivatives
05/08/2003WO2002085414A3 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
05/08/2003WO2002085341A3 Composition, containing carnitine and huperzin for the preventionor treatment of learning disorders in children suffering from attention deficit/hyperactive disorder
05/08/2003WO2002064129A3 Compositions of biochemical compounds involved in bioenergy metabolism of cells
05/08/2003WO2002060897A3 Process for making substituted 8-arylquinolinium benzenesulfonate
05/08/2003WO2002053089B1 Stable skin conditioning compositions containing retinoid boosters
05/08/2003WO2002049630A3 Method for preventing or treating pain by administering an endothelin antagonist
05/08/2003WO2002048152A3 Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines
05/08/2003WO2002039953A9 Texaphyrin coordination compounds and uses thereof
05/08/2003WO2002036110A3 Oral self-emulsifying formulations of pyranone protease inhibitors
05/08/2003WO2002026223A3 Catecholamine pharmaceutical compositions and methods
05/08/2003WO2002024715A3 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
1 ... 5474 5475 5476 5477 5478 5479 5480 5481 5482 5483 5484 5485 5486 5487 5488 5489 5490 5491 5492 5493 5494 ... 7860